Genetic risk factors for cancer-related cognitive impairment: a systematic review

References

• Cancer statistics [Internet]. NIH National Cancer Institute website; [cited 2018 Sep 4]. Available from: https://www.cancer.gov/about-cancer/understanding/statistics
   Google Scholar
• Ahles TA, Root JC. Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. 2018;14:425–451.
   PubMed Web of Science ®Google Scholar
• Joly F, Giffard B, Rigal O, et al. Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012. J Pain Symptom Manage. 2015;50:830–841.
   PubMed Web of Science ®Google Scholar
• Janelsins MC, Kesler SR, Ahles TA, et al. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26:102–113.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Kesler SR, Noll KR, et al. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015;65:123–138.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292–2299.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Hurria A, McDonald BC, et al. Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Semin Oncol. 2013;40:709–725.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Root JC, Ryan EL. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. JCO. 2012;30:3675–3686.
   PubMed Web of Science ®Google Scholar
• Morley KI, Montgomery GW. The genetics of cognitive processes: candidate genes in humans and animals. Behav Genet. 2001;31:511–531.
   PubMed Web of Science ®Google Scholar
• Liu C-C, Kanekiyo T, Xu H, et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106–118.
   PubMed Web of Science ®Google Scholar
• Savitz J, Solms M, Ramesar R. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav. 2006;5:311–328.
   PubMed Web of Science ®Google Scholar
• Weinberger DR, Egan MF, Bertolino A, et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 2001;50:825–844.
   PubMed Web of Science ®Google Scholar
• Malhotra AK, Kestler LJ, Mazzanti C, et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652–654.
   PubMed Web of Science ®Google Scholar
• Ng T, Teo SM, Yeo HL, et al. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer. Neuro Oncol. 2016;18:244–251.
   PubMed Web of Science ®Google Scholar
• Booth A, Clarke M, Dooley G, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339.
   Web of Science ®Google Scholar
• Sackett DL, Richardson WS, Rosenberg W, et al. Evidence-based medicine: how to practice and teach. New York (NY): Churchill Livingstone; 1997.
   Google Scholar
• NIH: Study Quality Assessment Tools [Internet]. NIH National Heart Lung and Blood; [cited 2018 Sep 4]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
   Google Scholar
• Ahles TA, Li Y, McDonald BC, et al. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology. 2014;23:1382–1390.
   PubMed Web of Science ®Google Scholar
• Koleck TA, Bender CM, Sereika SM, et al. Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. Oncol Nurs Forum. 2014;41:313–325.
   PubMed Web of Science ®Google Scholar
• Mandelblatt JS, Stern RA, Luta G, et al. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol. 2014;32:1909–1918.
   Web of Science ®Google Scholar
• Vardy JL, Stouten-Kemperman MM, Pond G, et al. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer. Brain Imaging Behav. 2017.
   PubMed Web of Science ®Google Scholar
• Bender CM, Merriman JD, Sereika SM, et al. Trajectories of cognitive function and associated phenotypic and genotypic factors in breast cancer. Oncol Nurs Forum. 2018;45:308–326.
   PubMed Web of Science ®Google Scholar
• Cheng HD, Li W, Gan C, et al. The COMT (rs165599) gene polymorphism contributes to chemotherapy-induced cognitive impairment in breast cancer patients. Am J Transl Res. 2016;8:5087–5097.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Saykin AJ, Noll WW, et al. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology. 2003;12:612–619.
   PubMed Web of Science ®Google Scholar
• Amidi A, Agerbaek M, Wu LM, et al. Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging Behav. 2017;11:769–783.
   PubMed Web of Science ®Google Scholar
• Vardy JL, Dhillon HM, Pond GR, et al. Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. JCO. 2015;33:4085–4092.
   PubMed Web of Science ®Google Scholar
• Vardy J, Dhillon HM, Pond GR, et al. Cognitive function and fatigue after diagnosis of colorectal cancer. Ann Oncol. 2014;25:2404–2412.
   PubMed Web of Science ®Google Scholar
• Small BJ, Rawson KS, Walsh E, et al. Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer. 2011;117:1369–1376.
   PubMed Web of Science ®Google Scholar
• Koleck TA, Bender CM, Sereika SM, et al. Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory study. Springerplus. 2016;5:422.
   PubMedGoogle Scholar
• Koleck TA, Bender CM, Clark BZ, et al. An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. BCTT. 2017;9:95–110.
   Web of Science ®Google Scholar
• Chae JW, Ng T, Yeo HL, et al. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) polymorphisms on cognitive impairment in Asian breast cancer patients. PLoS One. 2016;11:e0164204.
   PubMed Web of Science ®Google Scholar
• Gonzalez BD, Jim HSL, Booth-Jones M, et al. Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison. JCO. 2015;33:2021U54.
   Web of Science ®Google Scholar
• Peila E, D’Agata F, Caroppo P, et al. Chemotherapy-induced neurotoxicity: evidence of a protective role of CC homozygosis in the interleukin-1 beta gene-511 C > T polymorphism. Neurotox Res. 2016;30:521–529.
   PubMed Web of Science ®Google Scholar
• Urfer-Buchwalder A, Urfer R. Identification of a nuclear respiratory factor 1 recognition motif in the apolipoprotein E variant APOE4 linked to Alzheimer’s disease. Sci Rep. 2017;7.
   PubMed Web of Science ®Google Scholar
• Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. JCO. 2008;26:971–982.
   PubMed Web of Science ®Google Scholar
• ALZGENE [Internet]. Meta-analysis of all published AD association studies (case-control only) APOE_E2/3/4; date accessed: 9 March 2016]; [cited 2018 Sep 23]; 2010. Available from: http://www.alzgene.org/meta.asp?geneID=83
   Google Scholar
• Auton A, Brooks LD, Durbin RM, et al. A global reference for human genetic variation. Nature. 2015;526:68.
   PubMed Web of Science ®Google Scholar
• Rawle MJ, Davis D, Bendayan R, et al. Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course. Transl Psychiatry. 2018;8:18.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Vardy J, Ahles T, et al. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12:703–708.
   PubMed Web of Science ®Google Scholar
• Savage JE, Jansen PR, Stringer S, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912–919.
   PubMed Web of Science ®Google Scholar
• Rey A. L’examen psychologique dans les cas d’encephalopathie traumatique [The psychological examination in cases of traumatic encephalopathy]. Arch Psychol. 1941;28:286–340.
   Google Scholar
• Lezak MD. Neuropsychological assessment. 5th ed. Oxford: Oxford University Press; 2012. 1161 p.
   Google Scholar